United States - English - NLM (National Library of Medicine)

rebel distributors corp - naproxen sodium (unii: 9tn87s3a3c) (naproxen - unii:57y76r9atq) - naproxen sodium 375 mg - carefully consider the potential benefits and risks of naprelan® tablets and other treatment options before deciding to use naprelan® tablets. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings ). naprelan® tablets are indicated for the treatment of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, tendinitis, bursitis and acute gout. it is also indicated in the relief of mild to moderate pain and the treatment of primary dysmenorrhea. naprelan® is contraindicated in patients with known hypersensitivity to naproxen. naprelan® should not be given to patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin or other nsaids. severe, rarely fatal, anaphylactic-like reactions to nsaids have been reported in such patients (see warnings- anaphylactoid reactions , and precautions- preexisting asthma ). naprelan® is contraindicated for the treatment of peri-operative pain in the setting of cor

United States - English - NLM (National Library of Medicine)

shionogi inc. - naproxen sodium (unii: 9tn87s3a3c) (naproxen - unii:57y76r9atq) - naproxen 375 mg - carefully consider the potential benefits and risks of naprelan®  tablets and other treatment options before deciding to use naprelan®  tablets. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings). naprelan®  tablets are indicated for the treatment of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, tendinitis, bursitis and acute gout. it is also indicated in the relief of mild to moderate pain and the treatment of primary dysmenorrhea. naprelan®  is contraindicated in patients with known hypersensitivity to naproxen. naprelan®  should not be given to patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin or other nsaids. severe, rarely fatal, anaphylactic-like reactions to nsaids have been reported in such patients (see warnings- anaphylactoid reactions, and precautions- preexisting asthma). naprelan®  is contraindicated for the treatment of peri-operative pain in the setting of corona

United States - English - NLM (National Library of Medicine)

physicians total care, inc. - naproxen sodium (unii: 9tn87s3a3c) (naproxen - unii:57y76r9atq) - naproxen sodium 375 mg - carefully consider the potential benefits and risks of naprelan® tablets and other treatment options before deciding to use naprelan® tablets. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings ). naprelan® tablets are indicated for the treatment of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, tendinitis, bursitis and acute gout. it is also indicated in the relief of mild to moderate pain and the treatment of primary dysmenorrhea. naprelan® is contraindicated in patients with known hypersensitivity to naproxen. naprelan® should not be given to patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin or other nsaids. severe, rarely fatal, anaphylactic-like reactions to nsaids have been reported in such patients (see warnings- anaphylactoid reactions , and precautions- preexisting asthma ). naprelan® is contraindicated for the treatment of peri-operative pain in the setting of cor

United States - English - NLM (National Library of Medicine)

stat rx usa - naproxen sodium (unii: 9tn87s3a3c) (naproxen - unii:57y76r9atq) - naproxen sodium 750 mg - carefully consider the potential benefits and risks of naprelan® tablets and other treatment options before deciding to use naprelan® tablets. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings ). naprelan® tablets are indicated for the treatment of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, tendinitis, bursitis and acute gout. it is also indicated in the relief of mild to moderate pain and the treatment of primary dysmenorrhea. naprelan® is contraindicated in patients with known hypersensitivity to naproxen. naprelan® should not be given to patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin or other nsaids. severe, rarely fatal, anaphylactic-like reactions to nsaids have been reported in such patients (see warnings- anaphylactoid reactions , and precautions- preexisting asthma ). naprelan® is contraindicated for the treatment of peri-operative pain in the setting of cor

United States - English - NLM (National Library of Medicine)

almatica pharma inc. - naproxen sodium (unii: 9tn87s3a3c) (naproxen - unii:57y76r9atq) - naproxen 375 mg - naprelan tablets are indicated for the treatment of: • rheumatoid arthritis (ra) • osteoarthritis (oa) • ankylosing spondylitis (as) • tendinitis, bursitis • acute gout • primary dysmenorrhea (pd) • the relief of mild to moderate pain [see warnings and precautions (5)] . naprelan is contraindicated in the following patients: - known hypersensitivity (e.g., anaphylactic reactions and serious skin reactions) to naproxen or any components of the drug product [see warnings and precautions (5.7, 5.9) ] - history of asthma, urticaria, or other allergic-type reactions after taking aspirin or other nsaids. severe, sometimes fatal, anaphylactic reactions to nsaids have been reported in such patients [see warnings and precautions (5.7, 5.8) ] - in the setting of coronary artery bypass graft (cabg) surgery [see warnings and precautions (5.1) ] risk summary use of nsaids, including naprelan, can cause premature closure of the fetal ductus arteriosus and fetal renal dysfunction leading to oligohydramnios an

United States - English - NLM (National Library of Medicine)

bryant ranch prepack - naproxen sodium (unii: 9tn87s3a3c) (naproxen - unii:57y76r9atq) - naproxen sodium 375 mg

Canada - English - Health Canada

alkermes inc - naproxen (naproxen sodium) - tablet (extended-release) - 375mg - naproxen (naproxen sodium) 375mg - other nonsteroidal antiimflammatory agents

Canada - English - Health Canada

alkermes inc - naproxen (naproxen sodium) - tablet (extended-release) - 500mg - naproxen (naproxen sodium) 500mg - other nonsteroidal antiimflammatory agents

Jordan - English - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

شركة دار الدواء للتنمية والأستثمار - dar al dawa development and investment co ltd - norfloxacin 0.3 % - 0.3%

Ireland - English - HPRA (Health Products Regulatory Authority)

elan pharma ltd - capsule - 250 milligram